• About Us
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms and Conditions
Friday, March 20, 2026
  • Login
  • Register
StartupSuperb
  • NewsLatest
    • Trending
    • International Insights
    • Reports
  • Funding FlowJust In
  • Artificial Intelligence
  • Tech
  • Marketing
  • Resources
    • Books
  • Shark Tank
    • Shark Tank India
  • Startup Stories
    • Founder Fridays
    • Superb Shepreneurs
No Result
View All Result
  • NewsLatest
    • Trending
    • International Insights
    • Reports
  • Funding FlowJust In
  • Artificial Intelligence
  • Tech
  • Marketing
  • Resources
    • Books
  • Shark Tank
    • Shark Tank India
  • Startup Stories
    • Founder Fridays
    • Superb Shepreneurs
No Result
View All Result
StartupSuperb
No Result
View All Result
  • News
  • Funding Flow
  • Artificial Intelligence
  • Tech
  • Marketing
  • Insights
  • Resources
  • Shark Tank
  • Startup Stories
  • Social Superb
ADVERTISEMENT
Home News

Pine Labs’ IPO Soars to $2.7 Billion Valuation: Peak XV Seeks 40X Gains as Invesco Faces Setbacks

Akash Das by Akash Das
November 3, 2025
in News
Reading Time: 6 mins read
0
A A
0
Pine Labs’ IPO Soars to .7 Billion Valuation: Peak XV Seeks 40X Gains as Invesco Faces Setbacks
ADVERTISEMENT
Share on LinkedInShare on FacebookShare on X.comSend on TelegramSend on WhatsApp



Pine Labs IPO Price Band and Valuation Insights

Highlights

  • 1 Pine Labs IPO Price Band and Valuation Insights
    • 1.1 Investor Returns and Gains
      • 1.1.1 Challenges for Late-Stage Investors
    • 1.2 Financial Gains from the OFS
      • 1.2.1 Market Correction Reflected in Valuation
    • 1.3 Details of the IPO Structure
      • 1.3.1 Major Stakeholders in Pine Labs
    • 1.4 Company Financial Performance
      • 1.4.1 Implications for Future Fintech IPOs

Pine Labs IPO Price Band and Valuation Insights

Fintech unicorn Pine Labs has revealed its IPO price range as Rs 210-221 per share, valuing the firm at approximately Rs 23,573 crore, or $2.7 billion. This highly anticipated public offering provides excellent exit opportunities for initial investors but presents challenges for some later-stage backers.

Investor Returns and Gains

According to an analysis by Startup Superb, Peak XV Partners, formerly known as Sequoia Capital India, is set to enjoy the most significant return, boasting a 39.5X return on its investment. Madison India and Sofina Ventures are also positioned to realise substantial profits, projecting returns of 5.6X and 4.7X, respectively.

ADVERTISEMENT

Challenges for Late-Stage Investors

On the contrary, investors who entered during subsequent funding rounds may experience substantially lower returns or, in some cases, losses. Temasek and PayPal are predicted to achieve less than a 3X return on their investments, while Mastercard is expected to reach a 1.7X return. Invesco, which invested at one of the highest valuations, may face a loss due to the IPO pricing being lower than their entry point. Lone Cascade might barely cover their costs with a 1.2X return.

Financial Gains from the OFS

During the Offer for Sale (OFS), Peak XV Partners is expected to collect around Rs 508.4 crore, closely followed by Actis, which may receive Rs 194.7 crore, Temasek with Rs 193.3 crore, PayPal at Rs 150 crore, and Mastercard with Rs 130.9 crore. Other investors, such as Invesco (Rs 71 crore), Madison India (Rs 66.7 crore), Lone Cascade (Rs 53 crore), Sofina Ventures (Rs 44.2 crore), and the founder Lokvir Kapoor (Rs 49.1 crore), will also see partial cash-outs.

Market Correction Reflected in Valuation

The implied valuation of $2.7 billion indicates a notable decrease from the $6 billion target that Pine Labs was pursuing in 2022. This adjustment highlights a broader market re-evaluation of late-stage fintech valuations as investors shift their focus towards profitability and consistent cash flow instead of hyper-growth stories.

Details of the IPO Structure

Pine Labs is planning a Rs 3,900 crore IPO, which includes a new issue of Rs 2,080 crore alongside an OFS of 8.23 crore shares from existing investors. Funds raised from the new issue will be allocated for settling debts, enhancing technology, and expanding internationally.

Major Stakeholders in Pine Labs

According to the Red Herring Prospectus (RHP), Peak XV remains the largest external stakeholder with a 20.25% share, trailed by Temasek at 7.06% and PayPal at 5.98%. Actis Pine Labs Investment maintains a 5.75% stake, while Mastercard and Alpha Wave hold shares of 5.22% and 3.37%, respectively.

Company Financial Performance

Pine Labs registered a 28.5% increase in revenue year-on-year, reaching Rs 2,274 crore in FY25, up from Rs 1,769 crore in FY24. In the same timeframe, net losses reduced by 57%, totalling Rs 145 crore. Importantly, in the first quarter of FY26, the company achieved profitability, recording a net profit of Rs 4.7 crore on revenue of Rs 616 crore.

Implications for Future Fintech IPOs

If successful, this listing could spark renewed momentum in India’s fintech IPO market, benefiting companies like Razorpay and Cashfree. However, forthcoming offerings will likely seek more realistic valuations that align with current investor sentiments.


Tags: Pine Labs
ShareShareTweetShareSend
ADVERTISEMENT
Akash Das

Akash Das

Hi, I’m Akash, an entrepreneur, tech enthusiast, digital marketer, and content creator on a mission to inspire innovation and drive transformation through technology and creativity.My expertise extends to digital marketing, where I craft data-driven strategies for SEO, social media, and branding to empower businesses and creators to grow their online presence. Alongside my entrepreneurial journey, I share my insights and discoveries through engaging blogs, tutorials, and YouTube content.

Related Posts

Aamra Seniors Club Secures 0K in Pre-Seed Funding!

Aamra Seniors Club Secures $150K in Pre-Seed Funding!

March 20, 2026
2
StayVista Achieves Profitability in FY25 with ₹181 Crore in Revenue

StayVista Achieves Profitability in FY25 with ₹181 Crore in Revenue

March 20, 2026
0
L’Oréal in Negotiations to Acquire Innovist, the Parent Company of Bare Anatomy: Report

L’Oréal in Negotiations to Acquire Innovist, the Parent Company of Bare Anatomy: Report

March 19, 2026
0
Rymo Technologies Raises ₹10 Crore in Seed Funding for Neuro-Rehabilitation Innovations

Rymo Technologies Raises ₹10 Crore in Seed Funding for Neuro-Rehabilitation Innovations

March 19, 2026
0
“BHIM Soars from 15th to 6th Place with a Remarkable 4.7X Year-on-Year Volume Surge”

“BHIM Soars from 15th to 6th Place with a Remarkable 4.7X Year-on-Year Volume Surge”

March 19, 2026
0
Mave Health Secures .1 Million Investment from Blume Ventures to Transform Neurotechnology

Mave Health Secures $2.1 Million Investment from Blume Ventures to Transform Neurotechnology

March 19, 2026
0

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

ADVERTISEMENT
StartupSuperb

©️ All rights reserved startupsuperb

Navigate Site

  • About Us
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms and Conditions

Follow Us

Welcome Back!

Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Google
Sign Up with Linked In
OR

Fill the forms bellow to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • News
    • Exclusive
    • International Insights
    • Reports
  • Funding Flow
  • Artificial Intelligence
  • Tech
  • Marketing
  • Insights
  • Resources
    • Books
  • Shark Tank
    • Shark Tank India
  • Startup Stories
    • Founder Fridays
    • Superb Shepreneurs
  • Social Superb

©️ All rights reserved startupsuperb

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Go to mobile version